MedTech Cybersecurity Standards
FDA guidance, AAMI consensus standards, ISO quality and risk frameworks, IEC software lifecycle, NIST cybersecurity controls - they overlap, conflict in places, and together define what reviewers expect. This hub maps the standards landscape and links each one to the services and guides that operationalize it.
Services
- Full-Service FDA Premarket Cybersecurity
Full-service, end-to-end: we deliver 100% of the artifacts FDA reviewers expect for 510(k), De Novo, and PMA submissions - traceable, complete, and aligned with current 524B guidance.
- FDA Postmarket Cybersecurity
Once cleared, your device still needs eyes on it. We handle SBOM monitoring, coordinated vulnerability disclosure, patching, and FDA-aligned reporting.
- Medical Device Threat Modeling
Comprehensive threat modeling per FDA Section V.A.1 - covering supply chain, deployment, environment of use, and decommission risks for the full device system.
- FDA-Compliant SBOM Services
Machine- and human-readable SBOMs with NTIA minimum elements, vulnerability mapping, and end-of-support tracking - built for FDA review.
In-depth guides
- The MedTech Cybersecurity Standards DecoderA plain-English field guide to FDA Section 524B, IEC 81001-5-1, AAMI TIR57, ANSI/AAMI SW96, ISO 14971, and 8 more medical device cybersecurity standards. What they require, how they connect, and what the FDA expects to see in your eSTAR premarket submission.
- The SPDF PlaybookSPDF PLAYBOOK · FDA CYBERSECURITY GUIDE The SPDF Playbook for FDA-Ready Medical Devices A practical, ungated guide to building a Secure Product Development Framework that FDA accepts. The eight pillars, the artifacts each one produces, and a pre-submission readiness checklist you can score yourself
Standards & guidance
Defined entries from our MedTech Cybersecurity Standards Glossary.
- FDA 2026 GuidanceFDA Premarket Cybersecurity Guidance (Feb 3, 2026)The FDA's final premarket cybersecurity guidance, effective February 3, 2026. Defines the seven-section cybersecurity submission format reviewers now enforce at Technical Screening, replacing the 2023 draft. Operationalizes Section 524B of the FD&C Act.
- Section 524BFD&C Act Cyber Device RequirementsAdded by the Consolidated Appropriations Act, 2023, Section 524B gives the FDA explicit authority to require a complete cybersecurity package in every premarket submission for a cyber device, and to refuse submissions that lack one.
- ANSI/AAMI SW96Medical Device Security Risk ManagementThe consensus standard for medical device security risk management - asset, threat, vulnerability, likelihood, severity, and residual risk acceptability.
- AAMI TIR57Principles for Medical Device Security – Risk ManagementThe MedTech-specific extension of ISO 14971 for cybersecurity. Defines how to identify cybersecurity assets, threats, and vulnerabilities, then estimate, evaluate, and control the resulting risk.
- AAMI TIR97Postmarket Security Risk ManagementPostmarket companion to TIR57/SW96 - CVE monitoring, vulnerability triage, patching, and coordinated disclosure.
- ISO 13485Medical Device Quality Management SystemThe international QMS standard for MedTech. Covers design controls, document control, CAPA, supplier management, and post-market surveillance. The QMSR final rule (effective Feb 2, 2026) harmonizes 21 CFR Part 820 with ISO 13485.
- ISO 14971Medical Device Risk ManagementThe umbrella risk-management standard for medical devices. Defines hazard identification, risk estimation, risk evaluation, risk control, and residual risk evaluation. Cybersecurity risks must be reconciled here so a security control never silently introduces a safety hazard.
- IEC 81001-5-1Health Software Security ActivitiesThe international standard the FDA points to for the Secure Product Development Framework (SPDF). Defines security activities at each lifecycle stage - planning, requirements, design, implementation, V&V, release, and post-market.
- IEC 62443-4-1Secure Product Development LifecycleIndustrial-strength secure-development-lifecycle requirements applied to connected medical devices.
- NIST CSF 2.0Cybersecurity FrameworkSix functions: Govern, Identify, Protect, Detect, Respond, Recover. Not MedTech-specific, but commonly used by health-system customers as their procurement bar - so device makers need to map their controls to it.
- eSTARElectronic Submission TemplateFDA's mandatory interactive submission template with structured upload slots for each cybersecurity artifact.
- SPDFSecure Product Development FrameworkA documented framework that shows security activities are integrated across the device lifecycle - not bolted on at the end. Includes secure requirements, threat modeling, secure coding, V&V, vulnerability management, and post-market response.
From the blog
- AAMI TIR57 Risk Management for Medical DevicesA practical guide to AAMI TIR57 (R2023) and how it supports FDA’s Feb 2026 cybersecurity guidance - risk analysis, controls, and evidence.
- 21 CFR Part 820 and Medical Device CybersecurityUpdated October 26, 2024 The development, manufacturing, and management of medical devices require strict regulatory adherence to ensure these products' safety, effectiveness, and reliability. A key regulatory framework governing this process is 21 CFR Part 820, often called the Quality System Regul
- A New Era for Quality and Safety: What the FDA’s QMSR Means for CybersecurityFDA’s QMSR is now in effect. See why connected MedTech teams must build cybersecurity into the QMS - risk management, V&V, suppliers, and postmarket.
MedTech Cybersecurity Standards - frequently asked questions
Get FDA cleared without the cybersecurity headaches.
30-minute strategy session. No cost, no commitment - just answers from people who've shipped 250+ submissions.
